Showing results (81-90 of 110) with videos related to
Sort By:
Pageof 11
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 3, 2015
The Impact of Enhanced Screening and Treatment on Hepatitis C in the United StatesDavid P Durham, Laura A Skrip, Robert Douglas Bruce, et al.AIDS and Behavior|December 19, 2007
Initiation, adherence, and retention in a randomized controlled trial of directly administered antiretroviral therapyDuncan Smith-Rohrberg Maru, R Douglas Bruce, Mary Walton, et al.American Journal of Community Psychology|February 6, 2018
Interaction Effects of Neighborhood Disadvantage and Individual Social Support on Frequency of Alcohol Use in Youth Living with HIVLeslie Ann D Brick, Nicole R Nugent, Shoshana Y Kahana, et al.Addiction Research & Theory|September 21, 2020
Medical, therapeutic, and recreational use of cannabis among young men who have sex with men living with HIVDouglas Bruce, Alida M Bouris, Shannon Bowers, et al.The International Journal on Drug Policy|March 28, 2016
Improvements in health-related quality of life among methadone maintenance clients in Dar es Salaam, TanzaniaOmary Ubuguyu, Olivia C Tran, Robert Douglas Bruce, et al.AIDS and Behavior|October 19, 2016
First Report of Gender Based Violence as a Deterrent to Methadone Access Among Females Who Use Heroin in Dar es Salaam, TanzaniaDivya Balaji, Linda B Mlunde, Olivia C Tran, et al.The American Journal of Drug and Alcohol Abuse|February 21, 2013
Pharmacokinetic interactions between buprenorphine/naloxone and raltegravir in subjects receiving chronic buprenorphine/naloxone treatmentR Douglas Bruce, David E Moody, Diane Chodkowski, et al.Antimicrobial Agents and Chemotherapy|October 2, 2013
Investigation of the interactions between methadone and elvitegravir-cobicistat in subjects receiving chronic methadone maintenanceR Douglas Bruce, P Winkle, J M Custodio, et al.Journal of the International AIDS Society|November 14, 2014
Evaluation of drug-drug interaction between daclatasvir and methadone or buprenorphine/naloxoneTushar Garimella, Reena Wang, Wen-Lin Luo, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|April 20, 2013
The pharmacokinetic and pharmacodynamic interactions between buprenorphine/naloxone and elvitegravir/cobicistat in subjects receiving chronic buprenorphine/naloxone treatmentRobert Douglas Bruce, Peter Winkle, Joseph M Custodio, et al.Pageof 11